Akso Health Group ADR is a prominent player in the healthcare sector, dedicated to advancing innovative medical solutions and delivering holistic patient care services. Leveraging cutting-edge health technologies, the company actively explores opportunities in telehealth and personalized medicine, underpinned by a robust commitment to research and development. With a resilient business model and a skilled workforce, Akso Health Group offers a compelling investment prospect for institutional investors seeking to engage with the transformative advancements in the healthcare industry.
| Revenue (TTM) | $14.84M |
| Gross Profit (TTM) | 148,580 |
| EBITDA | $-1.46M |
| Operating Margin | -20.50% |
| Return on Equity | -68.30% |
| Return on Assets | -1.42% |
| Revenue/Share (TTM) | $0.03 |
| Book Value | $0.23 |
| Price-to-Book | 6.74 |
| Price-to-Sales (TTM) | 88.31 |
| EV/Revenue | 89.3 |
| EV/EBITDA | -0.39 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.90% |
| Shares Outstanding | $854.04M |
| Float | $2.56B |
| % Insiders | 0.00% |
| % Institutions | 0.03% |
Volatility is currently expanding